Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2
Public ClinicalTrials.gov record NCT00654797. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Process Improvement With A Bedside Computerized Insulin Therapy Protocol For Blood Glucose Control (eProtocol-insulin) in Adult And Pediatric Intensive Care Unit Patients-Second Phase (Phase-2): Distribution and Implementation of Validated eProtocol-insulin in Naïve ICUs
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Purpose of this study is to: 1. Introduce the refined, validated, and safe computerized bedside decision support tool for blood glucose management in critically ill adult and pediatric ICU patients that was studied in Phase 1 into a second group of naïve ICUs, none of which participated in eProtocol-insulin development, refinement or validation 2. Monitor how often low blood sugar levels occur during use of the bedside tool. 3. Determine how the computerized tool effects the workload of the ICU nurses.
Study identification
- NCT ID
- NCT00654797
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 1 Month and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2007
- Primary completion
- Nov 30, 2017
- Completion
- Nov 30, 2018
- Last update posted
- Feb 25, 2015
2007 – 2018
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Childrens Hospital Centeral California | Madera | California | — | Recruiting |
| Childrens Hospital of Minnesota - St. Paul | Saint Paul | Minnesota | — | Recruiting |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | — | Recruiting |
| Cornell University Medical College | New York | New York | — | Recruiting |
| Mount Sinai Hospital | New York | New York | — | Recruiting |
| Wake Forest University Baptist Medical Center | Winston-Salem | North Carolina | — | Recruiting |
| Ohio State University | Columbus | Ohio | — | Recruiting |
| University of Texas Medical Branch at Galveston | Galveston | Texas | — | Recruiting |
| Ben Taub General Hospital | Houston | Texas | — | Recruiting |
| MD Anderson Cancer Center | Houston | Texas | — | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00654797, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 25, 2015 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00654797 live on ClinicalTrials.gov.